2.A new drug BEOVU (brolucizumab) has been approved by the FDA for the treatment of wet macular degeneration. Wet age related macular degeneration is the main cause of blind registration in UK. BEOVU is manufactured by Novartis and is an anti-vascular endothelial...
A new study from University of Virginia School of Medicine found that exercise can prevent or slow down the progression of macular degeneration and may also benefit other causes of vision loss, such as diabetic retinopathy. Exercise can slow or prevent vision loss,...
